Personalized mRNA vaccine (intismeran)

At the WSJ Leadership Institute CEO Summit, Johnson & Johnson chairman and CEO Joaquin Duato said the company aims to ‘try to eliminate cancer’ within the next 10 ye...

A multicenter clinical trial enrolling 157 patients in Australia and the U.S. tested a personalized mRNA cancer vaccine (intismeran, developed by Moderna) given toge...